Advertisement

Topics

Evotec adds to CRO capabilities in $300 million deal

07:18 EDT 31 Jul 2017 | thePharmaLetter

Germany's Evotec has announced that it is to buy US contract research organization (CRO) Aptuit in a…

Original Article: Evotec adds to CRO capabilities in $300 million deal

NEXT ARTICLE

More From BioPortfolio on "Evotec adds to CRO capabilities in $300 million deal"

Quick Search
Advertisement
 

Relevant Topics

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...